CDER Conversations
CDER Conversation: The Latest in Drug Shortages
Drug shortages can occur for many reasons, including manufacturing and quality problems, production delays, and product discontinuations. Manufacturers provide FDA with information related to potential drug shortages, and the agency works closely with them to prevent or reduce the impact of shortages.
In this CDER Conversation Emily Thakur, CDR, United States Public Health Service, Team Leader for CDER’s Drug Shortage Staff (DSS), talks about recent drug supply challenges, shares new FDA guidance, and offers solutions to mitigate drug shortages.